Literature DB >> 10692901

Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure.

J E Scoble1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10692901      PMCID: PMC1297389          DOI: 10.1177/014107689909201004

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  45 in total

1.  The effect of main artery occlusion of one kidney on blood pressure of dogs.

Authors:  H Goldblatt; E Haas; R L Klick; L V Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension.

Authors:  C Hoglund; H G Hutchinson
Journal:  Int J Clin Pract       Date:  1998-06       Impact factor: 2.503

3.  Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.

Authors:  M Reif; W B White; T C Fagan; S Oparil; T L Flanagan; D T Edwards; D J Cushing; E L Michelson
Journal:  Am J Cardiol       Date:  1998-10-15       Impact factor: 2.778

4.  A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.

Authors:  B Girvin; G D Johnston
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

5.  Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.

Authors:  C J Pepine; E Handberg-Thurmond; R G Marks; M Conlon; R Cooper-DeHoff; P Volkers; P Zellig
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

6.  Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.

Authors:  F Zannad; Z Chati; M Guest; F Plat
Journal:  Am Heart J       Date:  1998-10       Impact factor: 4.749

7.  Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  R A Preston; B J Materson; D J Reda; D W Williams; R J Hamburger; W C Cushman; R J Anderson
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

8.  Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks.

Authors:  W D Hall; J W Reed; J M Flack; C Yunis; J Preisser
Journal:  Arch Intern Med       Date:  1998-10-12

9.  Effects of losartan on hypertension and left ventricular mass: a long-term study.

Authors:  M A Tedesco; G Ratti; D Aquino; G Limongelli; G di Salvo; S Mennella; D Galzerano; D Iarussi; A Iacono
Journal:  J Hum Hypertens       Date:  1998-08       Impact factor: 3.012

10.  Valsartan and atenolol in patients with severe essential hypertension.

Authors:  R Cifkova; J Peleska; J Hradec; H Rosolová; E Pintérová; K Zeman; P Oddou-Stock; J Thirlwell; F Botteri
Journal:  J Hum Hypertens       Date:  1998-08       Impact factor: 3.012

View more
  1 in total

Review 1.  Investigating progressive unexplained renal impairment and hypertension.

Authors:  L A Ratnam; S R Nelson; A M Belli
Journal:  BMJ       Date:  2007-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.